ArticleCancers2022

Immune-Related Gene Signatures to Predict the Effectiveness of Chemoimmunotherapy in Triple-Negative Breast Cancer Using Exploratory Subgroup Discovery.

Olha Kholod et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.